During the periovulatory period, the induction of prostaglandin G/H synthase-2 (PTGS2) expression in cumulus cells and associated prostaglandin E2 (PGE2) production are implicated in the terminal differentiation of the cumulus-oocyte complex. During the present study, the effects of the PTGS2/PGE2 pathway on the developmental competence of bovine oocytes were investigated using an in vitro model of maturation, fertilization, and early embryonic development. The specific inhibition of PTGS2 activity with NS-398 during in vitro maturation (IVM) significantly restricted mitogen-activated protein kinase (MAPK) activation in oocytes at the germinal vesicle breakdown stage and reduced both cumulus expansion and the maturation rate after 22 h of culture. In addition, significantly higher rates of abnormal meiotic spindle organization were observed after 26 h of culture. Periconceptional PTGS2 inhibition did not affect fertilization but significantly reduced the speed of embryo development. Embryo output rates were significantly decreased on Day 6 postfertilization but not on Day 7. However, total blastomere number was significantly lower in embryos obtained after PTGS2 inhibition. The addition of PGE2 to IVM and in vitro fertilization cultures containing NS-398 overrode oocyte maturation and early embryonic developmental defects. Protein and mRNA expression for the prostaglandin E receptor PTGER2 were found in oocytes, whereas the PTGER2, PTGER3, and PTGER4 subtypes were expressed in cumulus cells. This study is the first to report the involvement of PGE2 in oocyte MAPK activation during the maturation process. Taken together, these results indicate that PGE2-mediated interactions between somatic and germ cells during the periconceptional period promote both in vitro oocyte maturation and preimplantation embryonic development in cattle.
INTRODUCTION
In the preovulatory follicle, the cumulus-oocyte complex (COC) displays terminal differentiation before its release into the oviduct and fertilization. Cumulus cells undergo an expansion process, whereas the oocyte, arrested at the dictyate stage, resumes meiosis. The resumption of meiosis, or oocyte maturation, is indicated by germinal vesicle breakdown (GVBD), which is then followed by chromatin condensation and the formation of meiotic spindles while the oocyte progresses through the maturation process. The transition from metaphase I (MI) to metaphase II (MII) is accompanied by extrusion of the first polar body. At the time of fertilization, the oocyte released from MII arrest completes the second meiotic division, extrudes the second polar body, and undergoes pronuclear formation. Oocyte maturation is also characterized by biochemical changes. The maturing oocyte is the site of phosphorylation events that activate or deactivate the proteins involved in progression of the cell cycle [1] . Several kinases, including members of the mitogen-activated protein kinase (MAPK) family, are activated by a kinase pathway during this period [2] . The MAPK, which is also termed extracellularregulated kinase (ERK), is a family of Ser/Thr protein kinases that requires dual phosphorylation on threonine and tyrosine residues to become fully activated [3] . Two MAPK isoforms, MAPK3 (ERK1, p44) and MAPK1 (ERK2, p42), display increasing activity throughout oocyte maturation, reaching maximum levels at the MII stage [4] . They play a pivotal role in oocyte meiotic cell cycle progression, participating in the regulation of spindle and chromatin organization [5] [6] [7] [8] .
Terminal differentiation of the COC occurs in a coordinated manner in cumulus and germinal cells, thus enabling the production of fertilizable eggs. The prostaglandin G/H synthase-2 (PTGS2)-derived prostaglandins produced by cumulus cells appear to constitute critical mediators of the cumulus expansion and oocyte maturation processes [9, 10] . A genetic alteration of PTGS2 activity leads to defects in terminal COC differentiation. Cumulus cells have been shown to fail to expand in PTGS2 À/À mice, and extrusion of the first polar body is rarely observed [11] [12] [13] . PTGS, also known as cyclooxygenase, catalyzes the conversion of arachidonic acid into prostaglandin H2 (PGH 2 ) [14] . The unstable intermediate, PGH 2 , is then converted into various PGs by specific terminal PG synthases. Two PTGS isoforms, PTGS1 and PTGS2, are found in mammals. Unlike the constitutively expressed isoenzyme PTGS1, the PTGS2 isoform is considered to be inducible. The endogenous luteinizing hormone (LH) surge triggers the up-regulation of PTGS2 expression in the preovulatory follicle [15] [16] [17] [18] [19] . The increase in follicular PTGS2 expression occurs between 4 and 30 h after the LH surge, depending on the species [16, 20, 21] . Cumulus PTGS2 expression persists throughout the periconceptional period [10, 17] . After ovulation, sustained high levels of PTGS2 expression are still detected in oviductal cumulus cells. High levels of PTGS2 expression in ovulatory COCs have been shown to result from a feedback loop of PTGS2-derived prostaglandins and epidermal growth factor (EGF)-like factors in mouse models [22] . Cumulus PTGS2 expression can be induced in vitro by taking the COCs away from their follicular environment and transferring them into culture media supplemented with EGF or EGF-like factors [22] [23] [24] . PGE2 is the main PTGS2-related prostaglandin produced by cumulus cells both in vivo and in vitro [13, 23, 25] . PGE2 acts on a group of G-protein-coupled receptors, of which there are four, corresponding to the PGE2 subtypes designated as PTGER1 to 4 [26] . Although all subtypes except PTGER1 have been identified in the COC of different mammalian species [13, 18, [27] [28] [29] , only the PTGER2 receptor appears to play a role in the terminal differentiation process. Mice devoid of PTGER2 display abortive cumulus expansion and fertilization defects [10, 30, 31] . Several studies in mice have demonstrated the involvement of PGE2-PTGER2 signaling in regulating the cumulus extracellar matrix reorganization that is required for successful sperm attraction, capture, and penetration [31] [32] [33] . Defective differentiation of the cumulus could explain the fertilization deficiency displayed by PTGER2 À/À female mice. However, the influence of PGE2 on oocyte maturation and subsequent developmental competence has so far been the subject of little study. In the present work, we used a wellestablished in vitro model of maturation (IVM), fertilization (IVF), and embryonic development (IVD) in cattle to explore the effects of periconceptional PTGS2/PGE2 activity on oocyte development. We used a specific PTGS2 inhibitor, NS-398, to elucidate the involvement of PGE2 in meiotic maturation and early embryonic development. In parallel, we assessed meiotic spindle organization, the status of chromatin condensation, and the level of MAPK activity within maturing oocytes. We also tried to determine PTGER receptors specifically expressed by cumulus and germinal cells. Finally, we investigated the fertilization and in vitro development capacity of differentially matured oocytes.
MATERIALS AND METHODS

COC Collection and Culture Conditions
Bovine ovaries were collected from the slaughterhouse, and COCs were aspirated from 3-to 6-mm antral follicles. Only oocytes surrounded by more than three compact layers of cumulus cells were selected. Following three washes in HEPES-buffered TCM199 (Sigma), groups of up to 50 immature COCs were transferred to four-well plates (Nunc) containing 500 ll of a defined maturation medium consisting of TCM199 supplemented with 10 ng/ml mouse EGF (Sigma) at 398C in a water-saturated atmosphere under 5% carbon dioxide. After well-defined culture periods of 0, 7, 22, or 26 h [34] , the COCs were harvested and processed in order to separate the cumulus cells from the oocytes. They were incubated for 5 min with hyaluronidase (1 mg/ml in PBS; Sigma) at 398C before repeated pipetting. After additional washes in HEPES-buffered TCM199, denuded oocytes were prepared for real-time quantitative RT-PCR, immunocytochemistry, or Western blot analysis. Additional samples of isolated cumulus cells were harvested after 22 h of culture for an analysis of PTGER expression. To assess cumulus expansion, images of COCs matured in vitro for 22 h were captured under an inverted microscope, and cumulus areas were measured using AxioVision software, version 4.6 (Zeiss). For developmental competence experiments, COCs matured in vitro for 22 h underwent IVF, as previously described [25] . Depending on the experiment, NS-398 (Cayman Chemicals), a selective PTGS2 inhibitor, alone or supplemented with PGE2 (Cayman Chemicals), was added into the maturation and fertilization medium. NS-398 and PGE2 were dissolved in dimethyl sulfoxide (DMSO; D-4540; Sigma). Stock solutions of NS-398 (0.8, 8, and 80 mM) and PGE2 (0.1, 1, and 10 mM) were prepared and stored at À208C until the day of use. On the day of the experiment, each stock underwent a further 1:1000 dilution in the culture medium to reach the desired concentrations. The final concentration of DMSO (0.5%, v/v) in culture medium was the same in all treatment groups. An additional group, containing the same volume of DMSO only, was included in each experiment as a control. After IVF, presumptive zygotes were denuded and transferred into 50-ll droplets (under paraffin oil) of modified synthetic oviduct fluid [35] supplemented with 4 mg/ml bovine serum albumin (BSA) and 10 mM glycin. The embryos were cultured for 7 days at 398C in a water-saturated atmosphere under 5% CO 2 /5% O 2 /90% N 2 . The day of fertilization was considered as Day 0. At Day 1 postfertilization (Day 1 of culture), noncleaved (one-cell) oocytes were separated from those that had cleaved and were stained with ethidium homodimer 2 (EthD-2; Molecular Probes Invitrogen) to determine oocyte status (MII, 2 pronuclei, or degenerated). At Day 4 of culture, the embryos were transferred into fresh medium. The stage of embryonic development (two, four, or eight cells, .8 cells, morula, blastocyst, or hatched blastocyst) was determined at Days 2, 3, 6, and 7 of culture. Some of the Day 6 and Day 7 embryos were stained with 4 0 ,6-diamidino-2-phenylindole (Molecular Probes Invitrogen) to determine the number of blastomeres. Embryos were viewed under a fluorescent microscope (Axioplan imaging Apotome apparatus, Zeiss). Z-sectioning image series were collected with an Axiocam MRm camera and processed using Axiovision. Stained cells were counted using the open-source software ImageJ (http://rsbweb. nih.gov/ij/). For PGE2-induced MAPK activity experiments, COCs were cultured for 7 h in maturation medium supplemented or not with NS-398 (8 lM). The COCs were then denuded or not, and treated further for 1 h with 1 lM PGE2. The remaining intact COCs were finally denuded, and all oocytes were subjected to MAPK activity assays. In addition, samples of oocytes were denuded at the GV stage and cultured for 6 or 8h in TCM199 alone supplemented or not with PGE2. All experiments were repeated independently in triplicate.
Radioimmunoassay of PGE2
The quantities of PGE2 produced by COCs during the 22-h IVM period and in the absence or presence of increasing doses of NS-398 (0.8, 8, or 80 lM) were measured in the culture medium, as previously described [25] .
Assessment of Nuclear Maturation
After culture, groups of 15 to 20 COCs per treatment and per experiment were harvested and subjected to nuclear status assessment. Denuded oocytes were fixed for 1 h with 2.5% (w/v) paraformaldehyde (Sigma) solution in PBS at 48C and washed twice with PBS. Fixed oocytes were permeabilized in PBS containing 0.05% (w/v) saponin (PBS/saponin; Sigma) for 1 h at 378C. The oocytes were then blocked in PBS/saponin containing 2% (w/v) BSA for 1 h at 378C. The labeling of microtubules was ensured by incubating oocytes in a mouse monoclonal antibody against a-tubulin (T-9026; Sigma), diluted with PBS/saponin (1:200) and containing 2%, BSA for 1 h at 378C. After four washes of 15 min with PBS/saponin containing 0.2% BSA, the oocytes were incubated for 1 h at room temperature, in darkness, with antimouse IgG antibody conjugated to fluorescein isothiocyanate (Jackson ImmunoResearch; Interchim) that had previously been diluted to 1:200 in PBS/saponin containing 2% BSA. The chromatin was stained using EthD-2 at a dilution of 1:2000 (1 lM) in 0.1 M phosphate buffer. Finally, the oocytes were mounted on slides with citifluor (Biovalley). The phosphorylation of histone H3 on Ser-10 was used as a marker of chromatin condensation [36, 37] . An immunohistodetection procedure using anti-histone H3 (phospho S10) rabbit polyclonal antibody (pS10-H3; Abcam) was performed as described above. The primary antibody anti-pS10-H3 and fluorescein isothiocyanate-conjugated antirabbit IgG antibody (Jackson ImmunoResearch; Interchim) were used at a dilution of 1:200. Omissions of the primary antibodies were used as negative controls. The immunofluorescent-labeled oocytes and cumulus cells were viewed under a fluorescent microscope (Axioplan imaging Apotome apparatus). Images were captured with an Axiocam MRm camera and processed using Axiovision. Oocyte maturation was scored according to the criteria previously described [4] . GVBD stages were characterized by disappearance of the GV and high condensation of the chromatin. The MI stage was characterized by condensed chromosomes aligned in a large spindle and nonextrusion of the first polar body. The MII stage was characterized by condensed chromosomes aligned in a spindle and extrusion of the first polar body.
Assessment of MAPK Activity
Oocyte MAPK activity was determined indirectly by the detection of phosphorylated (active) forms of MAPK using phospho-MAPK3/1 Western blot analysis. For each treatment, three pools of 10 denuded oocytes were analyzed. Samples of oocytes were dissolved in 20 ll denaturing/loading and heated at 1008C for 5 min. Samples underwent electrophoresis in SDS-10% polyacrylamide gel and were electrotransferred onto a Hybond-P, polyvinylidene difluoride membrane (GE Healthcare). The membranes were then treated for the immunodectection of MAPK3/1 and phospho-MAPK3/1 as previously described [38] . The membranes were probed with mouse monoclonal phospho-MAPK3/1 antibody (Cell Signaling Technology; Ozyme) used at a dilution of 1:1000. The blots were then stripped and reprobed with rabbit polyclonal MAPK3/1 antibody (Santa Cruz; Tebu-Bio) used at a dilution of 1:5000. Peroxidase-conjugated donkey antimouse and antirabbit IgG (Jackson ImmunoResearch; Interchim) were diluted to 1:40 000 and 1:100hairsp;000, respectively. Immunoreactive signals were revealed using the ECL Plus Western blotting detection kit (GE Healthcare), visualized with a FujiFilm LAS-1000 camera system and analyzed by Advanced Image Data Analysis software (FujiFilm Life Science; FSVT). The molecular weights of the proteins identified were calculated using ProSieve color protein markers (Lonza).
Analysis of PTGER Receptor Expression in Oocytes and Cumulus Cells Using Real-Time PCR
In order to produce cDNA for standard curves in real-time PCR, total RNA (1 lg) from bovine ovary was reverse transcribed in a 20-ll mixture using oligo-dT primer and Superscript II reverse transcriptase (Invitrogen; Life Technologies). Complementary DNA for PTGER2, PTGER3, PTGER4, PTGS2, and ACTB were generated by conventional PCR on a thermal block cycler (Biometra), as previously described [25] . The primer sequences were either designed using the Genetic Computer Group (Wisconsin Package) Web interface or obtained from the literature (Table 1) [39, 40] . All PCR products were cloned into a plasmid vector (pCR4-TOPO; Invitrogen; Life Technologies) using a standard procedure (TOPO TA Cloning; Invitrogen; Life Technologies). All fragments were sequenced to confirm their identity. Appropriate cDNA to be used as standards in real-time PCR quantifications were generated by conventional PCR, and 1 ng of plasmid was added as the DNA matrix. All cDNA were stored at À208C after purification through a column (Geneclean turbo kit; Bio 101) until required for real-time PCR analysis. Messenger RNA levels for PTGER2, PTGER3, PTGER4, PTGS2, and ACTB were analyzed using real-time RT-PCR with an ABI Prism 7000HT (Applied Biosystems). Because PTGS2 is only expressed by expanding cumulus cells, the contamination of denuded oocyte samples by residual cumulus cells was assessed by PTGS2 expression analysis. For each treatment, three pools of 10 denuded oocytes or cumulus cells from 10 COCs were analyzed. Total RNA was extracted using the PicoPure RNA isolation kit (MDS Analytical Technologies) in accordance with the manufacturer's protocol. First-strand cDNA synthesis was carried out from total RNA using an oligo-dT primer and Super Script II reverse transcriptase (Invitrogen; Life Technologies). Messenger RNA amplifications were performed using the SYBR green Master Mix (Applied Biosystems). All reactions used a quantity of cDNA equivalent to 0.25 oocyte or cumulus, 0.3 lM of each primer, and an annealing temperature of 608C. The primers designed were based on cDNA sequences (produced as described above) using Design software (Primer Express; Applied Biosystems; Table 1 ). For all factors, five log dilutions of the appropriate purified cDNA were included in each assay and used to generate a standard curve. Following PCR, a melting curve was performed on the amplified products to ensure that only specific PCR amplicons had been obtained and quantified. The expression of all target mRNAs was determined in each sample during independent assays. PCR reactions were set up in duplicate. The median value of PCR duplicates was considered and then expressed as a ratio to ACTB mRNA for each sample. Data are presented as means 6 SD of three replicates.
Detection of PTGER2 by Immunohistochemical Analysis
Denuded oocytes and isolated cumulus cells were subjected to PTGER2 immunohistodetection using the same procedure as that described above. Rabbit polyclonal anti-PTGER2 antibody (Cayman; SPIbio) was used at a dilution of 1:100. Fluorescein isothiocyanate-conjugated antirabbit IgG antibody was used at a dilution of 1:200 (Jackson ImmunoResearch; Interchim).
Detection of PTGER2 by Immunoblotting Analysis
The expression of PTGER2 protein was investigated in pools of 30 denuded oocytes at the GV and MII stages. The immunoblot detection of PTGER2 was performed as described above. Membranes were probed with anti-PTGER2 antibody at a dilution of 1:500, followed by incubation with peroxidaseconjugated donkey antirabbit IgG (Jackson ImmunoResearch; Interchim) diluted 1:100 000.
Statistical Analysis
Differences in cumulus area, blastomere numbers at Days 6 and 7 of culture, and MAPK activity were analyzed for the effects of culture conditions using one-way ANOVA followed by Tukey post hoc tests. Values were expressed as means 6 SEM.
The rates of maturation, fertilization, cleavage, and development to the blastocyst stage were compared using chi-square analysis. Data from three replicates were pooled to calculate percentages based on the total number of oocytes subjected to IVM. Significant differences were defined as P , 0.05. Analyses were performed using Systat 11 software (Systat Software).
RESULTS
Inhibition of PTGS2 Activity During IVM Alters Cumulus Expansion and Oocyte Maturation
As shown in Figure 1 , a significant effect on both the cumulus expansion and oocyte maturation processes was evidenced when COCs were cultured in the presence of NS-398 (8 and 80 lM). The expanded cumulus area was significantly decreased by 20% and 25% in the presence of 8 lM and 80 lM of NS-398, respectively (P ¼ 0.004; Fig.  1A ). The proportion of oocytes at the MI stage increased from 5% and 6% without and with 0.8 lM NS-398, to 27% and 26% with 8 lM and 80 lM NS-398, respectively (P , 0.05; Fig 1, B and C) . Conversely, the proportion of MII oocytes fell from 95% and 94% in the control group and in the presence of 0.8 lM NS-398 to 67% and 48% in the presence of 8 lM and 80 lM NS-398, respectively (P , 0.05). PGE2 production corresponding to 1.8 6 0.37 pg per COC in the control group fell to undetectable levels in all NS-398-treated cultures. 
PTGS2 Inhibition Slows Down the Progression of In Vitro Meiosis and Alters MII Spindle Organization
No differences in the ability of oocytes to resume meiosis were observed between treatment groups. After 7 h of IVM, all oocytes cultured with (n ¼ 33) or without NS-398 (n ¼ 31) had undergone GVBD. After 22 h of IVM, the maturation rate was significantly lower in the NS-398-treated culture (P , 0.05; Table 2 ). Furthermore, morphological differences were evidenced in the MII oocyte population (Fig. 2 and Table 2 ). An analysis of chromatin compaction using pS10-H3 staining showed that the proportion of MII oocytes displaying an uncondensed polar body was significantly higher in NS-398-treated cultures than in the control group (P , 0.05). The ''uncondensed polar body'' phenotype was mainly observed earlier under control conditions after about 17 h of IVM (data not shown). We then compared oocyte status after 26 h versus 22 h of IVM. In the presence of NS-398, the proportion of MI oocytes significantly decreased during the additional 4 h of culture to reach the same level that had been observed at 22 h of IVM in the control group (P , 0.05; Table 2 ). This was associated with a significant rise in the incidence of abnormal nuclear maturation (P , 0.005). Microtubule organization of the meiotic spindle and chromosomal distribution appeared to be disturbed, as assessed by a-tubulin and EthD-2 staining (Fig. 3) . The proportion of MII oocytes remained unchanged between 22 h and 26 h in all treatment groups. However, in the NS-398-treated culture, the proportion of MII oocytes displaying an uncondensed polar body decreased significantly during the additional 4 h of culture, reaching a level similar to that observed at 22 h in the control group (P , 0.05; Table 2 ). Our results showed that PTGS2 inhibition during IVM did not prevent GVBD but delayed meiosis progression and disrupted spindle organization during MI-MII transition.
PGE2 Restores the Normal Progression of Oocyte Meiosis
The addition of PGE2 (1 lM or 10 lM) to cultures treated with 8 lm of NS-398 significantly decreased the proportion of MI oocytes to a level comparable to that observed in the   FIG. 1 . The inhibition of PTGS2 activity using NS-398 during the IVM of bovine COCs alters in vitro cumulus expansion (A; values are represented as mean 6 SEM) and oocyte maturation (B; *P , 0.05; **P , 0.01) after 22 h of culture. The morphology of MI and MII meiotic spindles appeared to be normal in all treatment groups as assessed by a-tubulin and EthD-2 staining (C). Bar ¼ 10 lm. 
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control group (P ¼ 0.001; Table 3 ). This was associated with a significant rise in the proportion of MII oocytes (P , 0.05). In addition, the incidence of the uncondensed polar body phenotype among the MII oocytes observed in cultures containing both NS-398 and PGE2 (1 or 10 lM) was similar to that observed in the control group. No significant changes to the levels of abnormal nuclear maturation were found in any of the treatment groups after the 22-h culture period. Our results thus showed that PGE2 overrode the meiosis progression defects induced by PTGS2 inhibition during IVM.
PGE2 Promotes MAPK Phosphorylation in Maturing Oocytes
After 7 h of IVM, MAPK phosphorylation started to increase in oocytes cultured both with and without NS-398. However, phospho-MAPK3/1 levels were significantly lower in oocytes cultured under PTGS2 inhibition (P , 0.05; Fig.  4A, lanes 0-2) . At the end of the 22-h culture period, similar levels of MAPK phosphorylation were determined in all treatment groups (data not shown). Our results thus showed that PTGS2 inhibition did not prevent MAPK activity in oocytes but restricted the enhancement of MAPK phosphorylation at the start of meiosis. In order to determine whether the effect of PTGS2 on MAPK phosphorylation could be mediated by PGE2, COCs maintained in the presence of 8 lM NS-398 for 7 h were treated with 1 lM PGE2 for an additional 1 h of culture. Intact COCs and denuded oocytes were subjected to PGE2 treatment to determine whether PGE2 could influence oocyte MAPK activity directly or indirectly via the cumulus cells. As shown in Figure 4A (lanes 3-5) , the level of phospho-MAPK3/1 rose dramatically within 1 h in oocytes exposed to PGE2 (P , 0.001), and this rise was similar in oocytes cultured with or without surrounding cumulus cells. When oocytes were denuded at the GV stage, the phospho-MAPK3/1 signal was detected after 6 h of culture in the presence of 1 lM PGE2. Any phospho-MAPK3/1 signal was not seen after 6 h of culture in the absence of PGE2, whereas it was evidenced from 8 h of culture (Fig. 4B) . Our results thus showed that PGE2 was able to act directly on maturing oocytes to enhance MAPK activity.
PTGER2 Is Expressed by Maturing Oocytes
Transcripts coding for PTGER2, PTGER3, and PTGER4 were detectable in cumulus cells, whereas only PTGER2 mRNA was expressed in oocytes (Fig. 5A) . PTGS2 mRNA was evidenced in cumulus cells, whereas no transcript for PTGS2 was detected in any denuded oocyte samples. We then examined the protein expression of the PTGER2 subtype in COCs. PTGER2 was immunohistochemically detectable in both cumulus cells and oocytes (Fig. 5B) . In addition, Western blot analysis showed that oocytes expressed a 52-kDa PTGER2 protein at the GV stage (Fig. 5C ).
Periconceptional Synthesis of PGE2 via PTGS2 Does Not Affect IVF but Influences the Kinetics of Early Embryonic Development
Cleavage rates were similar in all treatment groups (Table  4 ). In addition, no significant differences were observed regarding the distribution of uncleaved ovocytes among the MII, 2 pronuclei, and degenerated stages (data not shown). Differences between treatment groups were found with respect to the number of cells per embryo. At Day 2 and Day 3 of culture, the proportions of 2-cell embryos remained significantly higher after the exposure of COCs to NS-398 during the IVM/IVF period (P , 0.05; Fig. 6 ). Conversely, the proportions of embryos containing 6-8 cells at Day 2 of culture and more than 8 cells at Day 3 of culture were significantly smaller when compared to embryo cultures derived from the IVM/IVF control group (P , 0.05). In addition, the number of blastomeres in Day 6 and Day 7 embryos derived from the NS-398-treated IVM/IVF cultures remained significantly lower (P , 0.05; Table 5 ). The addition of PGE2 to NS398-treated IVM/IVF cultures restored a number of cells per embryo that was comparable to that evaluated in the control group. COCs that had matured and been fertilized in the presence of NS-398 led to the development of a significantly smaller number of morula/ blastocysts at Day 6 of culture when compared to the control group (P , 0.05; Table 4 ). The addition of PGE2 to NS-398-treated IVM/IVF cultures restored a developmental rate at Day 6 of culture that was comparable to that observed in the control group. At Day 7 of culture, the morula/blastocyst output rates were similar in all treatment groups. However, a significant difference in the Day 7 blastocyst hatching rate was observed as a function of IVM/IVF culture conditions (P , 0.05). No hatching was observed in embryo cultures derived from the IVM/IVF NS-398-treated group (0/52), whereas the proportion of hatched embryos corresponded to 11.5% (7/61) in embryo cultures derived from the IVM/IVF control group and 6.7% (4/ 60) in embryo cultures derived from the NS-398 groups supplemented with PGE2. Overall, these results suggest that periconceptional PGE2 synthesis in bovine cumulus cells is not required for the IVF process but affects the kinetics of early embryonic development.
DISCUSSION
This is the first study in non-genetically modified mammals on the influence of de novo PGE2 synthesized by expanding cumulus cells on oocyte developmental competence up to the blastocyst stage. We thus present new data that suggest that PTGS2-derived PGE2 acts directly on the oocyte via PTGER2 to activate the proteins involved in meiosis progression in cattle. In addition, we demonstrated subsequent effects of periconceptional PTGS2/PGE2 activity on the kinetics of preimplantation embryonic development.
Previous studies using genetically modified mice had shown that PTGS2-derived PGE2 contributes to successful terminal differentiation of the COC [10, 11, 13] . During the present study, we showed that a transient inhibition of PTGS2 activity during the IVM of bovine COCs also induced defective cumulus expansion and reduced oocyte maturation rates, as described in Ptgs2-deficient mice. Nevertheless, some differences in the kinetics of meiosis progression were noted. A deferred resumption of meiosis was evidenced in Ptgs2-null females [13] . This could at least partially explain the delay in meiosis progression found after both in vivo and in vitro maturation. In the present model, we demonstrated that the delay in meiosis progression induced by PTGS2 inhibition resulted from a lengthening of the maturation process between the GVBD and MII stages. Indeed, NS-398-treated oocytes did 
PGE2 EFFECTS ON OOCYTE MEIOSIS AND DEVELOPMENT
not display any delay in the resumption of meiosis, whereas they continued to progress through the MII stage during an additional IVM culture period as assessed by chromatin condensation analysis. However, this result definitively established that cumulus PTGS2 activity was involved in controlling the progression of oocyte meiosis. In Ptgs2-deficient mice, meiotic maturation defects were incompletely rescued by PGE2. It has been suggested that alternative pathways, such as the epidermal growth factor family, are more efficient than PGE2 in inducing oocyte maturation. Unlike the mouse model, PGE2 fully restored normal meiosis progression in NS-398-treated bovine oocytes. This result thus provided evidence that the effects of cumulus PTGS2 activity on oocyte maturation are mainly mediated by PGE2 in cattle. Interestingly, we observed the emergence of abnormal oocyte maturation when NS-398-treated IVM was pursued for a further 4 h. Although the meiotic spindle at meiosis I appeared to be normal, the delayed progression from MI to meiosis II led to spindle abnormalities and aberrant spindle pole organization. This observation suggests that PTGS2 activity could contribute to regulating microtubule organization during the progression of oocyte meiosis, particularly during the MI/MII transition. It is generally accepted that MAPK activity is required to maintain spindle integrity during oocyte meiosis progression [5] [6] [7] [8] . In the oocyte, MAPK activation starts from the first hours of maturation and increases steadily as meiosis progresses [4] . In the present study, we showed that cumulus PTGS2 activity enhanced the level of active phosphorylated MAPK in oocytes at the beginning of meiosis, at around the GVBD stage. Moreover, we reported the ability of PGE2 to markedly boost NS-398-restricted MAPK activation in maturing oocytes and to promote MAPK activation in denuded oocytes. Taken together, these data demonstrate the ability of PTGS2-related PGE2 to act as a direct enhancer of oocyte MAPK activity during the maturation process. Expression of the PGE2 receptor subtypes PTGER2, PTGER3 and PTGER4 has been reported in mouse and bovine COCs [13, 18, [27] [28] [29] . Studies using genetically modified mice have provided evidence that only PTGER2 plays a key role in terminal differentiation and fertilization-related processes [10, 41] . Our investigations revealed that PTGER2 is the only PGE2 receptor subtype expressed in bovine oocytes throughout the maturation process, whereas PTGER2, PTGER3, and PTGER4 are expressed in cumulus cells. This observation is consistent with the fact that PGE2 is able to trigger oocyte MAPK activation directly, even in the absence of surrounding cumulus cells. Unlike bovine oocytes, PTGER expression was not detected in mouse oocytes [10, 13] . It has been speculated that the primary targets of PGE2 in the mouse are cumulus cells and not oocytes. Impaired oocyte maturation induced by PTGER antagonists could be a secondary effect resulting from defective cumulus expansion. The present data concerning cellspecific PTGER expression confirm that the bovine oocyte may be a direct target for PGE2, and they open new possibilities with respect to downstream PGE2 signaling pathways within maturing oocytes.
PTGS2-or PTGER2-null oocytes display a marked reduction in fertilizing capacity, both in vivo and in vitro [10, 11, 13] . It has been suggested that this drop in fertilization rates mainly results from impaired cumulus expansion. In the present study, the transient inhibition of PTGS2 activity during the periconceptional period did not alter fertilization, as assessed by the cleavage rate, even if cumulus expansion was defective. In addition to regulating fertilization-related processes, prostaglandins are involved in regulating several other reproductive processes such as gonad development [42] . PGE2 has recently been presented as a key regulator of germ cell differentiation during ovarian development [43] . The defective fertilization displayed by PTGS2 or PTGER2 null oocytes could reflect alterations to germ cell differentiation that occur earlier during gonadogenesis. However, a reduction in the in vitro developmental potential of fertilized eggs was noted in both Ptgs2-deficient mice [13] and the present bovine models. Our kinetic analysis revealed that preimplantation development was slowed down in response to PTGS2 inhibition during the periconceptional period. Indeed, the number of blastomeres per embryo remained smaller after NS-398 treatment, as assessed by cell counts at Days 2, 3, 6, and 7 of culture. In addition, PTGS2 inhibition led to a lower embryo output rate at Day 6 of culture, whereas no difference in embryo rates was found between treatment groups at Day 7 of culture. PGE2 treatment during the preovulatory period in Ptgs2-null mice or during NS-398-treated IVM and IVF of bovine COCs largely restored normal in vitro development. Taken together, previous and present data provide evidence that the periconceptional actions of PTGS2-derived PGE2 are involved in the regulation of subsequent embryonic development. Further experiments will be needed to determine the distinct PGE2 effect related to 
PTGS2 activity that occurs during the maturation or fertilization period. The mechanisms underlying the effects of PGE2 on bovine blastomere proliferation still need to be explored.
Previous in vivo studies showed that the time elapsing between the induction of PTGS2 expression in the preovulatory follicle and the release of COC into the oviduct was remarkably conserved between species [44, 45] . Indeed, ovulation always occurs 10 h after the LH-mediated increase in PTGS2 expression. It has been suggested that the PTGS2 pathway may coordinate a cascade of events, each of which in terms of time, sequence, and amount is critical for successful ovulation-related processes. Here, we noted the ability of PTGS2-derived PGE2 to influence the kinetics of both oocyte meiosis and blastomere mitosis. Based on our data, and that of others, we hypothesize that PGE2 may serve as a molecular determinant for the timely regulation of cell cycle progression, synchronizing the differentiation of oocytes with the time of fertilization and early embryonic development with the maternal environment during its transit in the oviduct.
To summarize, we report here that periconceptional PTGS2 activity in cumulus cells and associated PGE2 production directly enhances oocyte MAPK activity during the resumption of meiosis in cattle. We have also demonstrated the ability of PGE2 to stimulate cell cycle progression during in vitro oocyte maturation and early embryonic development. A greater understanding of the molecular mechanisms by which PGE2 exerts its immediate effects on the maturation process and its late effects on embryonic development will help to clarify the complex interactions that occur between germinal and somatic cells during the terminal differentiation of COCs.
